Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Efficacy and safety of ritonavir dose reduction based on the tipranavir inhibitory quotient in HIV-infected patients on salvage antiretroviral therapy with tipranavir/ritonavir.

Moltó J, Valle M, Santos JR, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Clotet B.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1191-6. doi: 10.1089/aid.2009.0304. Epub 2010 Sep 23.

PMID:
20860529
2.

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.

Moltó J, Valle M, Santos JR, Mothe B, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Barbanoj MJ, Clotet B.

Antivir Ther. 2010;15(2):219-25. doi: 10.3851/IMP1519.

PMID:
20386077
3.

Comparative bioavailability of two formulations of sibutramine.

Franco Spínola AC, Almeida S, Filipe A, Neves R, Abolfathi Z, Yritia M, Anctil D.

Int J Clin Pharmacol Ther. 2009 Oct;47(10):627-37.

PMID:
19825326
4.

Bioequivalence of two formulations of levetiracetam.

Franco Spínola AC, Almeida S, Filipe A, Neves RI, Tanguay M, Yritia M.

Int J Clin Pharmacol Ther. 2008 Nov;46(11):591-6.

PMID:
19000558
5.

Bioequivalence study of two different film-coated tablet formulations of losartan-hydrochlorothiazide in healthy volunteers.

Neves R, Almeida S, Filipe A, Spínola AC, Abolfathi Z, Yritia M, Ortuño J.

Arzneimittelforschung. 2008;58(8):369-75. doi: 10.1055/s-0031-1296523.

PMID:
18807576
6.

Bioequivalence study of two tablet formulations of sildenafil.

Spínola AC, Almeida S, Filipe A, Tanguay M, Yritia M.

Arzneimittelforschung. 2008;58(3):122-5.

PMID:
18488808
7.

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.

Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ.

J Pharmacol Exp Ther. 2003 Jul;306(1):73-83. Epub 2003 Mar 26.

PMID:
12660312
8.

Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca.

Yritia M, Riba J, Ortuño J, Ramirez A, Castillo A, Alfaro Y, de la Torre R, Barbanoj MJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 5;779(2):271-81.

PMID:
12361741
9.

Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction.

Yritia M, Parra P, Fernández JM, Barbanoj JM.

J Chromatogr A. 1999 Jun 18;846(1-2):199-205.

PMID:
10420612
10.

Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?

Lahmame A, del Arco C, Pazos A, Yritia M, Armario A.

Eur J Pharmacol. 1997 Oct 22;337(2-3):115-23.

PMID:
9430405

Supplemental Content

Loading ...
Support Center